Overview
Xuewei Jiang practices practicing medicine in Jiangyin, China.
Their clinical expertise encompasses Lung Metastases, Squamous Cell Lung Carcinoma, Pectus Excavatum, and Lung Adenocarcinoma.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Xuewei Jiang
Is Xuewei Jiang a top-rated expert for Lung Metastases?
MediFind is an objective health platform that identifies experts based on real-world data. Xuewei Jiang is classified as an Experienced expert for Lung Metastases, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xuewei Jiang participate in research or clinical trials?
Yes. Xuewei Jiang has published 8 articles and abstracts on conditions like Lung Metastases. You can view a list of Xuewei Jiang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lung AdenocarcinomaJiang isExperienced. Learn about Lung Adenocarcinoma.
- Lung MetastasesJiang isExperienced. Learn about Lung Metastases.
- Pectus ExcavatumJiang isExperienced. Learn about Pectus Excavatum.
- Squamous Cell Lung CarcinomaJiang isExperienced. Learn about Squamous Cell Lung Carcinoma.